This article relates to the changes in left ventricular mass and strain parameters detected following intensive pharmacological treatment of grade II-III hypertension.
What is the current state/problem in practice?
Current ESC guidelines recommend rapid treatment of moderate and severe hypertension, though the consequences of this for the myocardium is unknown. Hypertensive heart disease is also a leading cause of heart failure - a lack of understanding of the effects of hypertension on myocardial structure and function may influence treatment inertia in this regard.
What is the ideal state/ if the problem is gone?
A greater understanding of the benefits of intensive treatment of hypertension would promote the adoption of this strategy amongst clinicians, conforming with contemporary guidelines and potentially improving patient outcomes.
To close the gap outlined above:
1. Learners need to know about: Regression of left ventricular hypertrophy and changes in myocardial function with intensive antihypertensive treatment.
2. Learners need to know how to apply: The concept of time-critical treatment of hypertension, as recommended in current guidelines.
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relationships to disclose.
Disclosure of Commercial Support
Please see the bibliography at the end of the journal article.